Literature DB >> 10225853

Effect of early antibiotic treatment on the antibody response to cytoplasmic proteins of Brucella melitensis in mice.

R A Bowden1, G C Racaro, P C Baldi.   

Abstract

To test whether antibiotic therapy hampers the antibody response to Brucella antigens, 30 BALB/c mice were infected with Brucella melitensis H38 and randomized for treatment with doxycycline administered intraperitoneally for 42 days starting at 7 or 28 days postinfection (p.i.) (groups DOX7 and DOX28, respectively) or for no treatment (control group). Antibodies to smooth lipopolysaccharide (LPS) reached peak levels (mean optical density [OD] = 2.618) between days 56 and 70 p.i. in the control group, and similar peak levels (mean OD = 2.486) were observed in the DOX28 group, but significantly lower peak levels (mean OD = 0.821) were observed at 28 days p.i. in the DOX7 group. The antibody response against cytoplasmic proteins depleted of LPS (CPs) reached maximal levels (mean OD = 2.402) between days 56 and 70 p.i. in the control group, but no response was detected in the DOX7 group. Anti-CP antibodies were detected in only three animals from the DOX28 group, at levels significantly lower than those in the control group (mean maximal OD = 0.791). The pattern of antibody response to an 18-kDa cytoplasmic protein of Brucella spp. was similar to that against the CP antigen. This study shows that early antibiotic treatment affects the antibody response of mice to cytoplasmic proteins of Brucella and, to a lesser extent, to LPS.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10225853      PMCID: PMC103740          DOI: 10.1128/CDLI.6.3.440-443.1999

Source DB:  PubMed          Journal:  Clin Diagn Lab Immunol        ISSN: 1071-412X


  13 in total

1.  Humoral immune responses of Brucella-infected cattle, sheep, and goats to eight purified recombinant Brucella proteins in an indirect enzyme-linked immunosorbent assay.

Authors:  J J Letesson; A Tibor; G van Eynde; V Wansard; V Weynants; P Denoel; E Saman
Journal:  Clin Diagn Lab Immunol       Date:  1997-09

2.  Determination by enzyme-linked immunosorbent assay of immunoglobulin G (IgG), IgM, and IgA to Brucella melitensis major outer membrane proteins and whole-cell heat-killed antigens in sera of patients with brucellosis.

Authors:  G F Araj; A F Kaufmann
Journal:  J Clin Microbiol       Date:  1989-08       Impact factor: 5.948

3.  Immunization of mice with recombinant L7/L12 ribosomal protein confers protection against Brucella abortus infection.

Authors:  S C Oliveira; G A Splitter
Journal:  Vaccine       Date:  1996-07       Impact factor: 3.641

4.  Differentiation between active and inactive human brucellosis by measuring antiprotein humoral immune responses.

Authors:  F A Goldbaum; C P Rubbi; J C Wallach; S E Miguel; P C Baldi; C A Fossati
Journal:  J Clin Microbiol       Date:  1992-03       Impact factor: 5.948

5.  Competitive enzyme-linked immunosorbent assay using monoclonal antibodies to the Brucella melitensis BP26 protein to evaluate antibody responses in infected and B. melitensis Rev.1 vaccinated sheep.

Authors:  H S Debbarh; M S Zygmunt; G Dubray; A Cloeckaert
Journal:  Vet Microbiol       Date:  1996-12       Impact factor: 3.293

6.  Protective immunity to Brucella ovis in BALB/c mice following recovery from primary infection or immunization with subcellular vaccines.

Authors:  M P Jiménez de Bagüés; P H Elzer; J M Blasco; C M Marín; C Gamazo; A J Winter
Journal:  Infect Immun       Date:  1994-02       Impact factor: 3.441

7.  Serological follow-up of human brucellosis by measuring IgG antibodies to lipopolysaccharide and cytoplasmic proteins of Brucella species.

Authors:  P C Baldi; S E Miguel; C A Fossati; J C Wallach
Journal:  Clin Infect Dis       Date:  1996-03       Impact factor: 9.079

8.  Antibiotic treatment induces an increase of the specific antibody levels in Brucella melitensis infected mice.

Authors:  S Domingo; R Díaz; C Gamazo
Journal:  FEMS Immunol Med Microbiol       Date:  1995-10

9.  Characterization of an 18-kilodalton Brucella cytoplasmic protein which appears to be a serological marker of active infection of both human and bovine brucellosis.

Authors:  F A Goldbaum; J Leoni; J C Wallach; C A Fossati
Journal:  J Clin Microbiol       Date:  1993-08       Impact factor: 5.948

10.  Characteristics of and risk factors for relapse of brucellosis in humans.

Authors:  J Ariza; J Corredoira; R Pallares; P F Viladrich; G Rufi; M Pujol; F Gudiol
Journal:  Clin Infect Dis       Date:  1995-05       Impact factor: 9.079

View more
  2 in total

1.  Early diagnosis and treatment of patients with symptomatic acute Q fever do not prohibit IgG antibody responses to Coxiella burnetii.

Authors:  C C H Wielders; L M Kampschreur; P M Schneeberger; M M Jager; A I M Hoepelman; A C A P Leenders; M H A Hermans; P C Wever
Journal:  Clin Vaccine Immunol       Date:  2012-08-22

Review 2.  What have we learned from brucellosis in the mouse model?

Authors:  María-Jesús Grilló; José María Blasco; Jean Pierre Gorvel; Ignacio Moriyón; Edgardo Moreno
Journal:  Vet Res       Date:  2012-04-13       Impact factor: 3.683

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.